Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-2 antagonists: the European perspective.

K-P Platz1, F Braun, F Fändrich

  • 1Department of Surgery, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Transplantation Proceedings
|May 28, 2005
PubMed
Summary

New immunosuppressive drugs like anti-interleukin-2 (IL-2) antibodies show promise in intestinal transplantation, potentially improving long-term survival over antilymphocyte preparations. Further research is needed to confirm efficacy and optimal use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No Evidence of Microsatellite Instability in Head and Neck Squamous Cell Carcinoma of Non-Smokers and Non-Drinkers.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2026
Same author

Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.

Translational oncology·2025
Same author

The effects of surface electrical stimulation plus voice therapy in Parkinson's disease.

The Journal of laryngology and otology·2022
Same author

Swallowing Assessment in Parkinson's Disease: Patient and Investigator Reported Outcome Measures are not Aligned.

Dysphagia·2020
Same author

"Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

AJNR. American journal of neuroradiology·2019
Same author

[Delayed diagnosis of Huntington's disease in a psychiatric setting].

Tijdschrift voor psychiatrie·2017

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Acute rejection is a primary challenge in intestinal transplantation.
  • Advances in immunosuppressive therapies have reduced severe acute rejection rates.
  • Optimal immunosuppressive strategies balancing efficacy and side effects are sought.

Purpose of the Study:

  • To compare the efficacy and patient survival rates of anti-interleukin-2 (IL-2) antibodies versus antilymphocyte preparations in intestinal transplantation.
  • To investigate the differential effects of these agents on T lymphocyte subsets, particularly regulatory CD4+ CD25+ T cells.

Main Methods:

  • Analysis of International Intestinal Transplant Registry data.
  • Comparison of long-term patient survival between patients receiving anti-IL-2 antibodies and antilymphocyte preparations.

Related Experiment Videos

  • Evaluation of the impact of different immunosuppressive agents on CD4+ CD25+ T lymphocyte populations.

    • Main Results:

    • Anti-IL-2 antibodies demonstrated a slight advantage in long-term patient survival compared to antilymphocyte preparations.
    • A key difference lies in the suppression of CD4+ CD25+ T lymphocytes by anti-IL-2 antibodies, while antilymphocyte preparations do not affect these cells.
    • Variability in dosing and protocols for both anti-IL-2 antibodies and antilymphocyte preparations necessitates further investigation.

    Conclusions:

    • Anti-IL-2 antibodies may offer improved long-term survival in intestinal transplantation.
    • The selective suppression of regulatory CD4+ CD25+ T cells by anti-IL-2 antibodies is a significant distinction.
    • Future protocols aiming for tolerance induction might consider omitting anti-IL-2 antibodies due to their effect on regulatory T cells.